Quinazolin-derived myeloperoxidase inhibitor suppresses influenza A virus-induced reactive oxygen species, pro-inflammatory mediators and improves cell survival.
Superoxide radicals and other reactive oxygen species (ROS) are implicated in influenza A virus-induced inflammation. In this in vitro study, we evaluated the effects of TG6-44, a novel quinazolin-derived myeloperoxidase-specific ROS inhibitor, on influenza A virus (A/X31) infection using THP-1 lung...
Guardado en:
Autores principales: | Juan A De La Cruz, Thota Ganesh, Becky A Diebold, Weiping Cao, Amelia Hofstetter, Neetu Singh, Amrita Kumar, James McCoy, Priya Ranjan, Susan M E Smith, Suryaprakash Sambhara, J David Lambeth, Shivaprakash Gangappa |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/80b3ccda96934ff1811aa0a4c2c44104 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
MYELOPEROXIDASE DEFICIENCY: SINGLE CENTER EXPERIENCE
por: Özlem ARMAN BİLİR, et al.
Publicado: (2021) -
New pathways for the synthesis of indolyl-containing quinazoline trifluoroacetohydrazides
por: Yu. A. Azev, et al.
Publicado: (2020) -
Enhanced neutrophil apoptosis accompanying myeloperoxidase release during hemodialysis
por: Taro Fukushi, et al.
Publicado: (2020) -
Dynamics of the Level of Myeloperoxidase and Serum Calprotectin in Local Cold Injury
por: M. I. Mikhailichenko, et al.
Publicado: (2020) -
SERUM MYELOPEROXIDASE, MALONDIALDEHYDE, ALPHA-SYNUCLEIN LEVELS IN PATIENTS WITH EPILEPSY
por: Fatma Şimşek, et al.
Publicado: (2021)